Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Have you been tested and confirmed to be HLA-A*02:01 positive?

This is a genetic test that determines if your immune system can respond to this treatment. Without this marker, the drug cannot be effective for you.

Show original medical criteria

HLA-A*02:01 positive status is required for tebentafusp to work, as the drug is designed to target cancer cells in patients with this specific genetic marker

This is informational only — not medical advice. Always discuss eligibility with your oncologist.

Eligibility Check — Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis — FindMyCure.ai